WHO Urges Pharmaceutical Companies To Reduce Cost Of Drugs - Liberty TV/Radio - News - Voice For All! Vision For Alll!
Publisher (F.BA)
July 29, 2019
TheWorld Health Organisation, WHO, Regional Director for Africa, Matshidiso Moetihas urged pharmaceutical companies and partners to reduce the cost of Hepatitis-Band C diagnosis and medicines to help sufferers.
Shemade the call at a news conference in Abuja to commemorate World Hepatitis Day,observed annually on July 28 to raise global awareness on the viral diseasewith the theme “Find the Missing Millions”.
Representedby the Officer-in-Charge WHO Nigeria, Clement Peter, Moeti said Hepatitis is asilent killer because most people do not know the symptoms and often do not getdiagnosed until late stages of the disease. She said there are five common typesof Hepatitis, namely Hepatitis A, B, C, D and E.
Accordingto Moeti, more than ninety five per cent of Hepatitis-related deaths are causedby chronic Hepatitis-B and C infections, while Hepatitis A and E rarely causelife-threatening illness.
Hepatitisis a viral infection that attacks the liver and can cause both acute andchronic diseases, commonly transmitted from mother to child during birth,as well as through contact with blood or other body fluids.